Kann, M



SignUp
(to Register)

Login
User Name
Password

Forgot Password?

About Maricel Kann (University of Maryland, Baltimore County)
Dr. Maricel Kann is an Assistant Professor at the University of Maryland, Baltimore County. She received a B.Sc. degree in Chemistry and a graduate degree in Pharmaceutical Chemistry from the Universidad de la Republica in Montevideo (Uruguay), where she was a research assistant in the Quantum Chemistry Department. In 2001, she obtained a doctoral degree from the University of Michigan in Chemistry. Her thesis work under the guidance of Dr. Richard A. Goldstein focused on the theory, statistics and methods for protein sequence alignment. After completing her Ph.D., Dr. Kann joined the Structure group at the National Center for Biotechnology Information (NIH) as a postdoctoral fellow. In August 2007, she joined the Department of Biological Sciences at UMBC as an Assistant Professor. Dr. Kann's research focuses on computational approaches to annotate the human genome with the goal of revealing the molecular underpinning of human diseases. One of the crucial steps after sequencing the genome is to classify and assign function to gene-encoded proteins. Dr. Kann's work addresses these challenges studying new computational methodologies to align, classify and predict interactions of proteins as well as to identify the role of certain mutations in the disease mechanisms. Dr. Kann is one of the leading experts in the area of translational Bioinformatics and has chaired several international conference sessions at the Pacific Symposium on Biocomputing (PSB), the Intelligent Systems and Molecular Biology (ISMB) and the American Medical Informatics Association (AMIA) Summit in Bioinformatics. She is a member of AMIA, the American Association for the Advancement of Science and the International Society of Computational Biology. Dr. Kann is part of the editorial boards of the Journal of Biomedical Informatics and the International Journal of Computational Models and Algorithms in Medicine and she is an advisory board member of the PubMedCentral National Committee.

Abstract
Using Correlated Evolution of Interacting Protein Domains to Predict their Interactions

Maricel Kann (University of Maryland, Baltimore County)

A clear understanding of the malfunctions that ultimately cause disease can only be achieved when the molecular details of the relevant protein interactions are known. Many protein interactions are mediated by protein units of compact structure. Computational tools to predict domain-domain interactions provide a detailed molecular view of the protein interactions and complements expensive and laborious experimental techniques to identify such interactions. The evolutionary distances of interacting proteins often display a higher level of similarity than those of non-interacting proteins. This finding indicates that interacting proteins are subject to common evolutionary constraints and constitute the basis of a method to predict protein interactions known as mirrortree. It has been difficult, however, to identify the direct cause of the observed similarities between evolutionary trees. One possible explanation is the existence of compensatory mutations between partners' binding sites to maintain proper binding. This explanation, however, has been recently challenged. It has been suggested that the signal of correlated evolution uncovered by the mirrortree method is unrelated to any correlated evolution between binding sites. We have addressed this controversial debate in the field by studying the contribution of binding sites to the correlation between evolutionary trees of interacting domains. We showed that binding neighborhoods of interacting proteins have, on average, higher co-evolutionary signal compared to the regions outside binding sites; although when the binding neighborhood was removed, the remaining domain sequence still contained some co-evolutionary signal. These results provide evidence of the role of compensatory mutations in protein co-evolution and contribute to our understanding of co-evolution of interacting proteins.

News and Announcements
Featured Panel Discussion
Personalised Medicine: Safety and Efficacy Concerns Discussed as a Case Study
Drug Discovery Workshop
Drug Discovery Design Methods
Oxford, 26-30 July 2010
Predictive ADME & Toxicology
Oxford, 2-6 August 2010
InnovationWell Workshop
Collaboration Forum
Philadelphia, 12 October 2009
InterAction Meetings 2009
Innovation in Life Science & Healthcare Research & Product Developement
Philadelphia, 13-16 October 2009
Knowledge Management Training
Certified Knowledge Manager,
19-23 April 2010
» Download Training Program Brochure
Virtual Proceedings for Members
» Integrating Knowledge in the Life Science Product Life Cycle
» Drug Safety Knowledge Management
Featured Talks for Visitors
Knowledge Management in Drug Safety - Sidney N Kahn, PvRM
Building the Drug Safety Body of Knowledge - Jim Averback, LSIP
The Ferryman Blog
KM & Community news
Sponsors

© Copyright 2004-2009 Colayer 
Colayer